8.2 C
New York
Thursday, March 28, 2024

Comment by phil

View Single Comment

  1. phil

    More color on Amgen’s Q1 results

    04:24 PM ET · AMGN

    • Product revenue: $4.36B (+4.9%).
    • Operating expenses: $3.16B (+12.9%).
    • Operating income: $1.36B (-5.4%).
    • Net Income: $1.07B (-25.2%).
    • EPS Basic: $1.42 (-25.7%).
    • CF Ops: $1.1B (+4.9%).
    • Neulasta/Neupogen: $1.38B (+3%).
    • Neulasta: $1.09B (+5%).
    • (AMGN)
    var isMC=true; var adSize=’320×50′; var ord = Math.floor(Math.random()*10e12); var seekingalpha_ad_src=’http://ad.doubleclick.net/N6001/adj/sek.mobile/app;sz=320×50,320×250;x=x;tile=1;d=mobile;t=app;mcid=true;mcid=1686383;s=AMGN;’+dart_my_vocation_and_profiles()+’ord=’+ord+’;dev=ip?’; document.write(”);



Stay Connected

157,453FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles